Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-618-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity: LD50 > 5000 mg/kg bw based on a study in rats similar to OECD TG 401
Acute inhalation toxicity: LC50 value of > 35000 mg/m³ has been calculated using route to route extrapolation.
Acute dermal toxicity: LD50 > 5000 mg/kg bw based on a study in rabbits similar to OECD TG 402
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- > 5 000 mg/kg bw
- Quality of whole database:
- One study is available which is sufficiently reliable to cover this endpoint sufficiently adequate.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Quality of whole database:
- The acute inhalation toxicity is derived using route to route extrapolation from the acute toxicity results using 100% absorption. This assessment is considered to be sufficiently adequate to cover this endpoint.
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- > 5 000 mg/kg bw
- Quality of whole database:
- One study is available which is sufficiently reliable to cover this endpoint sufficiently adequate.
Additional information
Acute oral toxicity
An acute oral toxicity study with the substance was conducted in rats, according to a protocol similar to OECD TG 401 and in compliance with GLP. Ten male Wistar rats received a single dose of 5000 mg/kg bw by gavage. Animals were observed for 14 days and necropsied. There were no deaths. Main clinical signs were chromorhinorrhea, ptosis and chromodacryorrhea. No findings were observed at gross pathology. Based on the results of the study, the LD50 was > 5000 mg/kg bw.
Inhalation route
No data on acute inhalation toxicity of the substance are available. According to Column 2 of REACH Annex VIII, “in addition to the oral route (8.5.1), for substances other than gases, the information mentioned under 8.5.2 (acute toxicity by inhalation) and 8.5.3 (acute toxicity by the dermal route) shall be provided for at least one other route. The choice for the second route will depend on the nature of the substance and the likely route of human exposure.” In the present case, inhalation exposure is expected to be lower than dermal because the substance has a low vapour pressure and dermal exposure is the more likely route of exposure. As acute toxicity data on both the oral and the dermal route of exposure is available, testing for acute inhalation toxicity is not necessary. However, the acute inhalation toxicity for the substance can be derived using data on the acute oral toxicity using the methodology presented in the next paragraph.
The oral LD50 of the substance is ≥ 5000 mg/kg bw. This 5000 mg/kg bw can be converted to 350000 mg/per person. An inhalation volume of one person during 4 h (standard exposure time in OECD TG for acute inhalation toxicity) is 5 m3 (assuming 10 m3/8h for workers). This means that the LC50 concentration in 1 m3 and 4 hours exposure is 70000 mg/m3.Taking into account that the absorption during inhalation route can be twice as high as during oral absorption the LC50 for inhalation would become 35000 mg/m3.The maximum saturated vapour pressure for this substance in mg/m3 is 1014 mg/m3 (13.4 Pa x 184280 MW (mg/Mol)) / (8.3 (R, gas constant) x 296°K).The LC50 value of 35000 mg/m3 cannot be reached because of the saturated vapour concentration of CP Formate of 1014 mg/m3.Though no correction has been done for rat versus human inhalation, the calculation clearly shows that there is no acute inhalation toxicity for the substance because the calculated LC50 = 35000 mg/m3, while the maximum saturated vapour pressure is 1014 mg/m3.
Acute dermal toxicity
An acute dermal toxicity study with the substance was conducted in rabbits, according to a protocol similar to OECD TG 402 and in compliance with GLP. An amount of 5.0 g/kg bw of the substance was applied to the clipped abdomen (ca. 10% body area) of 10 animals for 24 hours under occlusive conditions. The clipped sites of 1/2 of the animals were abraded with a bent tip needle. Six or seven abrasions ca. 2 -3 cm apart, extending the length of the exposure, were made. Abrasions were sufficiently deep to penetrate the stratum corneum, but not deep enough to produce bleeding. The plastic wrapping was removed and the test substance wiped after 24 hours and the animals were observed for 14 days and necropsied. Skin reactions were assessed at 24 hours post-dose and on days 7 and 14 using the numerical Draize scale. One animal died on day 7. The autopsy showed congested lungs and intestinal abnormalities. The main clinical signs in the survivors were alopecia and diarrhea. No pathological findings were found at necropsy in 3 out of 9 survivors; remaining animals showed signs of peritoneal cavity and intestinal abnormalities. Based on the results of the study, the LD50 was > 5000 mg/kg bw.
Justification for classification or non-classification
Based on oral and dermal LD50 > 5000 mg/kg bw in rats and rabbits, respectively, and the calculated inhalation LC50 of 35000 mg/m3, the substance does not need to be classified according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008 and its amendments.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.